These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32881991)

  • 1. We Thought We Created a Safety Net. We Were Wrong.
    Eaton EF
    Clin Infect Dis; 2021 Oct; 73(7):e1658-e1660. PubMed ID: 32881991
    [No Abstract]   [Full Text] [Related]  

  • 2. "Rapid Start" Treatment to End the (Other) Epidemic: Walking the Tightrope Without a Net.
    Eaton EF
    Clin Infect Dis; 2021 Feb; 72(3):479-481. PubMed ID: 31960032
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of Medications for Opioid Use Disorder on Discharge Against Medical Advice Among People Who Inject Drugs Hospitalized for Infective Endocarditis.
    Suzuki J; Robinson D; Mosquera M; Solomon DA; Montgomery MW; Price CD; Johnson JA; Martin B; Liebschutz JW; Schnipper JL; Weiss RD
    Am J Addict; 2020 Mar; 29(2):155-159. PubMed ID: 31930608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary on Gibson et al. (2020): Medications for opioid use disorder- access, retention, and safety.
    Timko C; Hoggatt K
    Addiction; 2020 Nov; 115(11):2077-2078. PubMed ID: 32458419
    [No Abstract]   [Full Text] [Related]  

  • 5. Utilization of buprenorphine and methadone among opioid users who inject drugs.
    Tsui JI; Burt R; Thiede H; Glick SN
    Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison table: some drugs for maintenance treatment of opioid use disorder.
    Med Lett Drugs Ther; 2017 May; 59(1521):e96-e97. PubMed ID: 28609422
    [No Abstract]   [Full Text] [Related]  

  • 7. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.
    Betts KS; Chan G; McIlwraith F; Dietze P; Whittaker E; Burns L; Alati R
    Addiction; 2016 Jul; 111(7):1214-23. PubMed ID: 26857811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs for opioid Use disorder.
    Med Lett Drugs Ther; 2017 Jun; 59(1522):89-95. PubMed ID: 28609420
    [No Abstract]   [Full Text] [Related]  

  • 9. Access to treatment for opioid use disorders: Medical student preparation.
    McCance-Katz EF; George P; Scott NA; Dollase R; Tunkel AR; McDonald J
    Am J Addict; 2017 Jun; 26(4):316-318. PubMed ID: 28394437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medications for addiction treatment initiated from the emergency department: Ethical considerations.
    Marshall KD; Derse AR; Iserson KV; Kluesner N; Vearrier L
    Am J Emerg Med; 2020 Feb; 38(2):343-348. PubMed ID: 31831343
    [No Abstract]   [Full Text] [Related]  

  • 11. Use and misuse of opioid agonists in opioid addiction.
    Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
    Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication-Assisted Treatment for Opioid-Use Disorder.
    Oesterle TS; Thusius NJ; Rummans TA; Gold MS
    Mayo Clin Proc; 2019 Oct; 94(10):2072-2086. PubMed ID: 31543255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs.
    Artenie AA; Minoyan N; Jacka B; Høj S; Jutras-Aswad D; Roy É; Gauvin L; Zang G; Bruneau J
    CMAJ; 2019 Apr; 191(17):E462-E468. PubMed ID: 31036608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming Barriers to Treatment of Opioid Use Disorder.
    Olsen Y; Fitzgerald RM; Wakeman SE
    JAMA; 2021 Mar; 325(12):1149-1150. PubMed ID: 33630021
    [No Abstract]   [Full Text] [Related]  

  • 15. Developing an advocacy agenda for increasing access to opioid substitution therapy as part of comprehensive services for people who use drugs in South Africa.
    Scheibe A; Marks M; Shelly S; Gerardy T; Domingo AK; Hugo J
    S Afr Med J; 2018 Oct; 108(10):800-802. PubMed ID: 30421704
    [No Abstract]   [Full Text] [Related]  

  • 16. Provider-directed marketing may increase prescribing of medications for opioid use disorder.
    Nguyen T; Andraka-Christou B; Simon K; Bradford WD
    J Subst Abuse Treat; 2019 Sep; 104():104-115. PubMed ID: 31370974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of Drugs Used to Treat Opioid Use Disorder.
    Aschenbrenner DS
    Am J Nurs; 2018 Aug; 118(8):25. PubMed ID: 30048283
    [No Abstract]   [Full Text] [Related]  

  • 18. Medication-Assisted Treatment of Adolescents With Opioid Use Disorders.
    COMMITTEE ON SUBSTANCE USE AND PREVENTION
    Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27550978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Puzzling about opiate substitution therapy: a synopsis and commentary.
    Adrian M
    Subst Use Misuse; 2013 Aug; 48(11):1022-3. PubMed ID: 23952513
    [No Abstract]   [Full Text] [Related]  

  • 20. Initiation of injectable opioid agonist treatment in hospital: A case report.
    McAdam M; Brar R; Young S
    Drug Alcohol Rev; 2020 Feb; 39(2):138-141. PubMed ID: 31814186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.